AbbVie- Big Gains In Small Molecule Drugs
October 25, 2020 at 11:20 AM EDT
AbbVie is a cutting-edge company specializing in small molecule drugs; the company has grown into the eighth-largest pharmaceutical company in the world. The stock is cheap. ABBV is selling about 30% below the 2018 high.